{"url_path":"/sec/cik-0001012477/8-k/2026-02-12/item-5-01","section_key":"item-5-01","section_title":"Item 5.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-02-12","source_url":"https://www.sec.gov/Archives/edgar/data/1012477/0001104659-26-013880-index.html","accession_number":"0001104659-26-013880","cik":"0001012477","ticker":null,"issuer_name":"AVADEL PHARMACEUTICALS PLC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1012477/0001104659-26-013880-index.html","primary_entity_key":"0001012477","primary_entity_name":"AVADEL PHARMACEUTICALS PLC"},"word_count":49,"has_tables":true,"body_markdown":"**Item 5.01**\n**Changes in Control of Registrant.**\n\n \n\nAs a result of the Scheme, a change in control of Avadel occurred,\nand Avadel became a wholly owned subsidiary of Alkermes.\n\n \n\nThe information set forth in Items 2.01, 3.01, 3.03, 5.02 and 5.03\nis incorporated by reference into this Item 5.01."}